• Explore /
  • Videos & Slides
  • / Two cycles versus three cycles of neoadjuvant sintilimab plus platinum-doublet chemotherapy in patients with resectable non-small-cell lung cancer (neoSCORE): A randomized, single center, two-arm phase II trial.

Two cycles versus three cycles of neoadjuvant sintilimab plus platinum-doublet chemotherapy in patients with resectable non-small-cell lung cancer (neoSCORE): A randomized, single center, two-arm phase II trial.

Abstract Video & Slides

Presenter

Fuming Qiu

Fuming Qiu

Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Videos & Slides Details

Meeting

2022 ASCO Annual Meeting

Session Type

Oral Abstract Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Biologic Correlates

Clinical Trial Registration Number

NCT04459611

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 8500)

DOI

10.1200/JCO.2022.40.16_suppl.8500

Abstract #

8500

Abstract Disclosures

Similar Videos & Slides

Videos & Slides

2019 ASCO Annual Meeting

The Changing Landscape of Small Molecules Over the Years

The Changing Landscape of Small Molecules Over the Years

Speaker: Jordi Rodon Ahnert, MD, MD, PhD, PhD

Speaker: Ming Song, MD

Speaker: Hui Liu

Speaker: Mariano Provencio-Pulla, MD, PhD